IRIS UniCatt

Baranello, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.912
EU - Europa 2.892
AS - Asia 2.381
SA - Sud America 456
AF - Africa 68
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.812
DE - Germania 1.189
SG - Singapore 1.119
CN - Cina 589
BR - Brasile 368
NL - Olanda 366
SE - Svezia 269
IT - Italia 229
FR - Francia 208
VN - Vietnam 173
GB - Regno Unito 139
UA - Ucraina 102
IE - Irlanda 99
IN - India 92
JP - Giappone 76
ID - Indonesia 67
FI - Finlandia 64
RU - Federazione Russa 58
CA - Canada 50
HK - Hong Kong 48
PL - Polonia 39
KR - Corea 36
AR - Argentina 35
BD - Bangladesh 33
IQ - Iraq 30
TR - Turchia 30
MX - Messico 28
BE - Belgio 23
AT - Austria 17
EC - Ecuador 16
ZA - Sudafrica 16
ES - Italia 14
EG - Egitto 12
MK - Macedonia 12
RS - Serbia 12
CH - Svizzera 11
PK - Pakistan 11
CO - Colombia 10
MA - Marocco 9
VE - Venezuela 9
LT - Lituania 8
TN - Tunisia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
PA - Panama 7
PE - Perù 7
PH - Filippine 7
SA - Arabia Saudita 7
CI - Costa d'Avorio 6
IL - Israele 6
MY - Malesia 6
CL - Cile 5
IR - Iran 5
AU - Australia 4
JO - Giordania 4
KE - Kenya 4
NP - Nepal 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
LV - Lettonia 3
SN - Senegal 3
TW - Taiwan 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
Totale 8.708
Salva come PNG Salva come JPEG
Città #
Singapore 666
Amsterdam 352
Ashburn 319
Chandler 316
San Jose 313
Frankfurt am Main 154
New York 153
Hefei 106
Los Angeles 103
Beijing 101
Dublin 82
Tokyo 76
Jacksonville 68
Munich 63
Ho Chi Minh City 62
Jakarta 61
Lauterbourg 61
Ann Arbor 55
Dallas 52
San Mateo 47
São Paulo 47
Hanoi 46
Hong Kong 46
Milan 44
Rome 44
Chicago 42
Nürnberg 40
Marseille 39
Dearborn 38
Boston 37
Seattle 37
Wilmington 36
Seoul 35
Nanjing 34
Buffalo 29
Moscow 29
Houston 28
Kent 25
Santa Clara 25
The Dalles 25
Warsaw 25
Council Bluffs 22
Montreal 22
Woodbridge 21
Brussels 20
London 20
Princeton 20
Denver 19
Helsinki 19
Atlanta 18
Fairfield 18
Orem 18
Paris 18
Turku 18
Brooklyn 17
Chennai 17
Lancaster 17
Nuremberg 17
Bremen 16
Nanchang 16
Poplar 15
Rio de Janeiro 14
Stockholm 14
Augusta 13
Baghdad 13
Hangzhou 13
Johannesburg 13
Palermo 13
Düsseldorf 12
Lawrence 12
Mexico City 12
Pune 12
Boardman 10
Leawood 10
Redwood City 10
Skopje 10
Changsha 9
Norwalk 9
Toronto 9
Haiphong 8
Hebei 8
Manchester 8
Mumbai 8
Phoenix 8
San Francisco 8
Secaucus 8
Shanghai 8
Vienna 8
Ankara 7
Belo Horizonte 7
Brasília 7
Cairo 7
Dhaka 7
Jinan 7
Lappeenranta 7
Lima 7
Portsmouth 7
Salvador 7
Tashkent 7
Washington 7
Totale 4.693
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 642
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 498
Cortical visual function in preterm infants in the first year. 275
Prognostic value of EEG performed at term age in preterm infants. 227
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 221
-Thalamic atrophy in infants with PVL and cerebral visual impairment 201
External hydrocephalus in discordant birth weight twins: a case report 182
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 181
Visual development in prenatal post-haemorragic ventricular dilatation 178
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 169
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 167
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 163
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 159
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 158
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 155
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 155
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 154
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 153
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 153
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 149
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 149
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 144
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 143
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 143
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 134
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 133
6 minute walk test in duchenne MD patients with different mutations:12 month changes 133
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016 133
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 129
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 129
antenatal post hemorrhagic ventriculomegaly: a prospective follow up study 127
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 126
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 126
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 123
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 119
The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy 119
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 118
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 115
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 113
Development of an International SMA Bulbar Assessment for Inter-professional Administration 111
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 109
Longitudinal natural history in young boys with Duchenne muscular dystrophy 109
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 106
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 105
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 103
Risdiplam in Type 1 Spinal Muscular Atrophy 101
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 98
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 97
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 95
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 89
null 81
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 77
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 76
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 75
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 75
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 73
Severe abnormalities of the pons in two infants with Goldenhar syndrome 72
null 64
The neurological examination of the newborn baby 61
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 60
Visual findings in infants with periventricular leukomalacia: 139 54
Visual development in infants with prenatal posthaemorrhagic ventricular dilatation 51
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 29
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 28
Totale 8.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 31 3
2021/2022384 19 17 19 41 25 15 7 64 29 23 61 64
2022/2023978 104 126 63 146 59 113 49 83 145 22 44 24
2023/2024635 36 131 20 40 25 134 61 18 5 23 63 79
2024/20251.373 24 26 99 45 123 73 53 56 176 109 326 263
2025/20264.176 464 115 256 466 748 946 544 179 222 224 12 0
Totale 8.795